Superior Long-Term Outcome With Idarubicin Compared With...

Superior Long-Term Outcome With Idarubicin Compared With High-Dose Daunorubicin in Patients With Acute Myeloid Leukemia Age 50 Years and Older

Gardin, C., Chevret, S., Pautas, C., Turlure, P., Raffoux, E., Thomas, X., Quesnel, B., de Revel, T., de Botton, S., Gachard, N., Renneville, A., Boissel, N., Preudhomme, C., Terre, C., Fenaux, P., Bo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2011.40.3642
Date:
January, 2013
File:
PDF, 184 KB
english, 2013
Conversion to is in progress
Conversion to is failed